Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. AU2003251515 - Cancer-linked gene as target for chemotherapy

Office
Australie
Numéro de la demande 2003251515
Date de la demande 09.06.2003
Numéro de publication 2003251515
Date de publication 16.10.2003
Type de publication A
CIB
C07K 14/47
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
KPEPTIDES
14Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés
435provenant d'animaux; provenant d'humains
46provenant de vertébrés
47provenant de mammifères
CPC
C07K 14/4748
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
4701not used
4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
Déposants AVALON PHARMACEUTICALS, INC.
Inventeurs Ebner, Reinhard
Données relatives à la priorité 60/387,399 10.06.2002 US
Titre
(EN) Cancer-linked gene as target for chemotherapy
Abrégé
(EN) Cancer-linked gene sequences, and derived amino acid sequences, are disclosed along with processes for assaying potential an titumor agents based on their modulation of the expression of these cancer-linked genes. Also disclosed are antibodies that react with the disclosed polypeptides and methods of using the antibodies to treat cancerous conditions, such as by using the antibody to target cancerous cells in vivo for purposes of delivering therapeutic agents thereto. Also described are methods of diagnosing using the gene sequences.
Documents de brevet associés